Question 1

What is BRINCIDOFOVIR used for?

Accepted Answer

BRINCIDOFOVIR (brand name Tembexa) is a Other indicated for 1 INDICATIONS AND USAGE TEMBEXA is an orthopoxvirus nucleotide analog DNA polymerase inhibitor and is indicated for the treatment of human smallpox disease in adult and pediatric patients, including neonates. 1.2 Limitations of Use TEMBEXA is not indicated for the treatment of diseases other than human smallpox disease [see Warnings and Precautions ( 5.1, 5.2 )] . The effectiveness of TEMBEXA for the treatment of smallpox disease has not been determined in humans because adequate and well-controlled field trials have not been feasible.

Question 2

How does BRINCIDOFOVIR work?

Accepted Answer

BRINCIDOFOVIR works through the following mechanism: 12.1 Mechanism of Action Brincidofovir is an antiviral drug against variola (smallpox) virus [see Microbiology ( 12.4 )] ..

Question 3

What are the most common side effects of BRINCIDOFOVIR?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for BRINCIDOFOVIR. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is BRINCIDOFOVIR the same as Tembexa?

Accepted Answer

Tembexa is a brand name for BRINCIDOFOVIR. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

BRINCIDOFOVIR

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations